PLAUR and neoplasm: Nb 15, an anti‐human uPAR targeting Nb, was selected as lead compound for potential clinical translation as it showed high tumor uptake and minimal non‐specific targeting in various tumor models, as evidenced by both in vivo SPECT/CT and fluorescent imaging data.